Sign inJoin waitlistJoin the waitlist

SA

Scott Aaronson

Adjunct Professor · Univ of Maryland Sch of Med

Credentials: · ·

History

Univ of Maryland Sch of Med
Present

Psychiatry
1981–1985
Harvard Medical School
1977–1981

Research

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
New England Journal of Medicine · 2022 · 867 citations
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice
Depression and Anxiety · 2012 · 282 citations
A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and…
American Journal of Psychiatry · 2017 · First of 9 authors · 260 citations

CC
Charles Conway
25 papers
Linda Carpenter
19 papers
DD
David Dunner
12 papers
Mark George
10 papers
John Zajecka
9 papers
KP
Kenneth Pages
9 papers
Patricio Posse
9 papers
TH
Todd Hutton
9 papers
MD
Mark Demitrack
8 papers
Paul Croarkin
8 papers
Gus Alva
7 papers
Michael Thase
7 papers

Clinical trials

The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Principal investigator · Completed · Phase 2
Sheppard Pratt Health System
2022–2025
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Principal investigator · Unknown · Phase 2
Sheppard Pratt Health System
2021–2026
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Principal investigator · Unknown · Phase 2
Sheppard Pratt Health System
2021–2023
An Open Label Trial of TMS Therapy for Bipolar Depression
Principal investigator · Completed
Sheppard Pratt Health System
2015–2020